Newsroom

Sorted by: Latest

-

Advanced MRI Imaging Reveals Changes in Muscle Composition and Fat Infiltration During Obesity Treatment

LINKÖPING, Sweden--(BUSINESS WIRE)--Advanced MRI Imaging Reveals Changes in Muscle Composition and Fat Infiltration During Obesity Treatment...
-

EADV 2026: Long-Term Disease Control for up to Five Years in Patients With Moderate-to-Severe Atopic Dermatitis Treated With Lebrikizumab

VIENNA--(BUSINESS WIRE)--Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today announced long-term results from ADlong, a Phase 3b open-label extension study evaluating the efficacy and safety of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis (AD). The late-breaking results of this long-term clinical study are presented at the 35th European Academy of Dermatology and Venereology (EADV) Congress, taking place in Vienna, A...
-

Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today presented detailed results from an ongoing Phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate-to-severe atopic dermatitis (AD). The study met its primary endpoint, demonstrating a statistically significant increase in the percentage of participants achieving EASI-75* (≥75% reduction in the Eczema Area and Severity Index) at Week 16 across all evaluated doses compared to placebo. The findings were shared today in...
-

ARKEMA INVESTIT 10 MILLIONS D’EUROS DANS SON CENTRE D’EXCELLENCE R&D MONDIAL DÉDIÉ AUX BATTERIES EN RÉGION LYONNAISE

PARIS LA DÉFENSE--(BUSINESS WIRE)--Regulatory News: Arkema (Paris:AKE) poursuit ses investissements dans la filière batteries et annonce un projet d’extension de 10 millions d’euros de son Centre d’Excellence Batteries mondial basé à Oullins-Pierre-Bénite, Auvergne-Rhône-Alpes. Cet investissement reflète la stratégie du Groupe visant à renforcer continuellement ses capacités de recherche dans les matériaux avancés pour batteries au sein de son réseau mondial de laboratoires R&D couvrant l’e...
-

Arkema Invests €10 Million in Its Global Battery R&D Center of Excellence in the Lyon Region

PARIS LA DÉFENSE--(BUSINESS WIRE)--Regulatory News: Arkema (Paris:AKE) continues to invest in the battery business value chain and announces a €10 million expansion project for its Global Battery Center of Excellence located in Oullins-Pierre-Bénite, in the Auvergne-Rhône-Alpes region of France. This investment reflects the Group's strategy of continuously strengthening its research capabilities in advanced materials for batteries within its global network of R&D laboratories covering the e...
-

Ares Strengthens Commitment to Plenitude Through €1 Billion Capital Contribution

LONDON--(BUSINESS WIRE)--Ares Management Corporation (NYSE: ARES), a leading global investment manager, announced today that Ares Alternative Credit funds (“Ares”) participated in a reorganization of the shareholding and governance structure of Plenitude through which Ares and Eni S.p.A (“Eni”) upsized their capital contribution by approximately €1.5 billion, of which over €1 billion is attributable to Ares, based on a pre-money equity valuation of Plenitude of €10.75 billion. Following complet...
-

ADS-TEC Energy Reports First Half 2026 Results; Advances Gigawatt-Scale SKM Storage Project and Strengthens its Position to Scale Own & Operate Model

NÜRTINGEN, Germany--(BUSINESS WIRE)--ADS-TEC Energy PLC (NASDAQ: ADSE) (the “Company”), a global leader in battery-based energy storage and fast-charging systems, today announced its unaudited interim condensed consolidated financial statements as of and for the six months ended June 30, 2026. First Half 2026 Highlights Market momentum building. After a period of general caution in the EV market, various industries are now looking forward to growth momentum. Battery-electric vehicle registratio...
-

Orifarm Unveils 2031 Strategy to Accelerate Growth Across Europe, With Significant Expansion in Generics

ODENSE, Denmark--(BUSINESS WIRE)--With its five-year strategy, Fit to Scale, Orifarm sets out an ambitious path to scale across Europe, including a major expansion of its prescription medicines business from a Nordic footprint to a broader European platform. The strategy aims to double EBITDA to €300m and generate more than €3bn in revenue by 2031, marking the next step in Orifarm's journey as a diversified European pharmaceutical company bringing affordable medicines to more customers, patient...
-

Thales Launches Sentinel Envelope Plus to Protect Software Against AI-Assisted Reverse Engineering

MEUDON, France--(BUSINESS WIRE)--Thales, a global leader in advanced technologies, today announced Sentinel Envelope Plus, a new addition to its Sentinel Envelope software protection solution that significantly hardens compiled applications against AI-assisted reverse engineering, automated zero-day vulnerability discovery, and automated exploit generation. Sentinel Envelope Plus applies multiple layers of protection to software applications, without requiring source code changes or any special...
-

Thales lance Sentinel Envelope Plus pour protéger les logiciels contre la rétro-ingénierie assistée par l'IA

PARIS--(BUSINESS WIRE)--Thales, leader mondial des hautes technologies, annonce aujourd'hui le lancement de Sentinel Envelope Plus. Ce nouveau module enrichit la solution de protection logicielle Sentinel Envelope de Thales et rend les applications bien plus résistantes aux attaques menées par l'IA : rétro-ingénierie, détection de failles zero-day et génération de vecteurs d’attaque. Sentinel Envelope Plus superpose plusieurs couches de protection, sans qu'il soit nécessaire de modifier le code...